Qualigen Therapeutics, Inc. (QLGN)
NASDAQ: QLGN · Real-Time Price · USD
3.870
+0.010 (0.26%)
At close: Nov 20, 2024, 4:00 PM
3.690
-0.180 (-4.65%)
After-hours: Nov 20, 2024, 7:44 PM EST
Qualigen Therapeutics Employees
Qualigen Therapeutics had 4 employees as of December 31, 2023. The number of employees decreased by 34 or -89.47% compared to the previous year.
Employees
4
Change (1Y)
-34
Growth (1Y)
-89.47%
Revenue / Employee
n/a
Profits / Employee
-$1,963,404
Market Cap
2.09M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4 | -34 | -89.47% |
Dec 31, 2022 | 38 | -8 | -17.39% |
Dec 31, 2021 | 46 | 8 | 21.05% |
Dec 31, 2020 | 38 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Venus Concept | 304 |
Xylo Technologies | 84 |
Scorpius Holdings | 84 |
Fresh2 Group | 75 |
Biodexa Pharmaceuticals | 21 |
Phio Pharmaceuticals | 9 |
Shuttle Pharmaceuticals Holdings | 8 |
GRI Bio | 4 |
QLGN News
- 19 days ago - Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024 - GlobeNewsWire
- 7 weeks ago - Qualigen Therapeutics, Inc. Announces management changes. - GlobeNewsWire
- 2 months ago - Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel - GlobeNewsWire
- 2 months ago - Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN) - GlobeNewsWire
- 2 months ago - Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering - GlobeNewsWire
- 2 months ago - Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering - GlobeNewsWire
- 6 months ago - Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination - GlobeNewsWire
- 8 months ago - Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting - GlobeNewsWire